We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

874 hedge funds and large institutions have $22.6B invested in United Therapeutics in 2026 Q2 according to their latest regulatory filings, with 106 funds opening new positions, 316 increasing their positions, 329 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more first-time investments, than exits

New positions opened: 106 | Existing positions closed: 70

3.37% more ownership

Funds ownership: 94.72% → 98.08% (+3.4%)

2% more funds holding

Funds holding: 853 → 874 (+21)

4% less call options, than puts

Call options by funds: $609M | Put options by funds: $633M

4% less repeat investments, than reductions

Existing positions increased: 316 | Existing positions reduced: 329

8% less capital invested

Capital invested by funds: $24.6B → $22.6B (-$2B)

31% less funds holding in top 10

Funds holding in top 10: 26 → 18 (-8)

Holders
874
Holders Change
+21
Holders Change %
+2.46%
% of All Funds
10.56%
Holding in Top 10
18
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-30.77%
% of All Funds
0.22%
New
106
Increased
316
Reduced
329
Closed
70
Calls
$609M
Puts
$633M
Net Calls
-$24.2M
Net Calls Change
-$67.2M

Top Buyers

Rank Fund Capital Flow
1
VPC
Vestal Point Capital
New York
+$203M
2
Jane Street
Jane Street
New York
+$159M
3
Millennium Management
Millennium Management
New York
+$144M
4
BG
Bellevue Group
Switzerland
+$105M
5
ACA
Avoro Capital Advisors
New York
+$83.2M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$499M
2
AQR Capital Management
AQR Capital Management
Connecticut
-$158M
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$133M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$91.2M
5
Invesco
Invesco
Georgia
-$76.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
TBFA
826
Three Bearings Fiduciary Advisors
New Hampshire
$4.33K – – –
HIA
827
HFM Investment Advisors
New Jersey
$4.33K +$2.82K +5 +167%
AS
828
Altshuler Shaham
Israel
$4.33K +$4.5K +8 New
AW
829
Avion Wealth
Texas
$4K – – –
MNA
830
Manning & Napier Advisors
New York
$3.81K +$3.94K +7 New
QWM
831
Quaker Wealth Management
New Jersey
$3.79K – – –
DWM
832
Dogwood Wealth Management
Kansas
$3.79K +$1.69K +3 +75%
AFC
833
Ares Financial Consulting
California
$3.79K +$2.25K +4 +133%
STB
834
S&T Bank
Pennsylvania
$3.79K +$3.94K +7 New
CPG
835
Cornerstone Planning Group
New Jersey
$3.69K – – –
VNA
836
Valley National Advisers
Pennsylvania
$3.25K – – –
FC
837
Financial Consulate
Maryland
$2.71K +$2.82K +5 New
MB
838
MidFirst Bank
Oklahoma
$2.71K – – –
WAS
839
Winch Advisory Services
Wisconsin
$2.71K – – –
GG
840
Gleason Group
Kentucky
$2.71K +$2.82K +5 New
MCM
841
Manchester Capital Management
Vermont
$2.17K – – –
PWA
842
Physician Wealth Advisors
Utah
$2.17K +$563 +1 +33%
FMP
843
Financial Management Professionals
Texas
$2.17K – – –
NEWAS
844
N.E.W. Advisory Services
Wisconsin
$2.17K – – –
JFA
845
JNBA Financial Advisors
Minnesota
$1.63K – – –
PAI
846
Pittenger & Anderson Inc
Nebraska
$1.63K +$1.69K +3 New
BWL
847
Bogart Wealth LLC
Virginia
$1.63K – – –
TM
848
Torren Management
California
$1.63K – – –
SWM
849
SHP Wealth Management
Massachusetts
$1.63K +$1.13K +2 +200%
QL
850
Quarry LP
New York
$1.63K +$1.69K +3 New
32 33
34
35 36

UTHR Hedge Fund Activity: Q2 2026 in Review

874 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q2 2026, worth a combined $22.6B — down 8.1% from $24.6B a quarter earlier.

Buyers outnumbered sellers: 106 funds opened new UTHR positions and 70 closed out — a net gain of 36 holders — while 316 added to existing stakes and 329 trimmed.

The largest buyer was Vestal Point Capital, adding an estimated $203M. The largest seller was Wellington Management Group, cutting an estimated $499M.

  • 874 institutional investors held United Therapeutics (UTHR) as of Q2 2026, up from 853 in Q1 2026.
  • Funds reported $22.6B of United Therapeutics stock for Q2 2026, down 8.1% quarter-over-quarter.
  • 106 funds opened new United Therapeutics positions in Q2 2026 and 70 closed out, a net change of +36 holders.
  • The largest United Therapeutics buyer in Q2 2026 was Vestal Point Capital, an estimated $203M added.
  • The largest United Therapeutics seller in Q2 2026 was Wellington Management Group, an estimated $499M sold.

Based on aggregated 13F filings for Q2 2026.